Presenting on Emerging Growth Conference 86 Day 2 September 25; Register to live stream Sep 24, 2025 07:00AM
Presenting on Emerging Growth Conference 85 Day 1 on August 20; Register to live stream Aug 19, 2025 07:00AM
Presenting on Emerging Growth Conference 84 Day 1 on July 16; Register to live stream Jul 15, 2025 07:00AM
Presenting on the Emerging Growth Conference 80, Day 1 on March 26 - Register Now Mar 25, 2025 07:00AM
Presenting on the Emerging Growth Conference 79 Day 2 on February 19 Register Now Feb 19, 2025 06:00AM


Jan 15, 2025 07:00AM Presenting on the Emerging Growth Conference 78 Day 2 on January 16 Register Now
Sep 24, 2024 07:00AM Presenting on the Emerging Growth Conference 75 Day 1 on September 25 Register Now
Aug 20, 2024 07:00AM Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now
Jul 17, 2024 07:00AM Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now
Jun 20, 2024 10:00AM Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
Dec 5, 2023 07:00AM Presenting on the Emerging Growth Conference 65 Day 1 on December 6th Register Now
Nov 1, 2023 07:00AM Presenting on the Emerging Growth Conference 64 Day 2 on November 2 Register Now
Oct 3, 2023 07:00AM Presenting on the Emerging Growth Conference 63 Day 1 on October 4 Register Now
Mar 10, 2022 09:07AM Geovax Labs Inc. (GOVX) Reports Publication of COH04S1, Showing it Produced Robust Antibodies and T cells Against SARS-CoV-2
Mar 10, 2022 09:03AM Geovax Labs (GOVX) Data Published in a Lancet Journal on COH04S1 Shows It Produced Robust Antibodies and T Cells Against SARS-CoV-2
Mar 10, 2022 09:00AM Data Published in a Lancet Journal on COH04S1, a City of Hope-Developed COVID-19 Vaccine, Shows it Produced Robust Antibodies and T cells Against SARS-CoV-2
Mar 10, 2022 09:00AM Data Published in a Lancet Journal on COH04S1, a City of Hope-Developed COVID-19 Vaccine, Shows it Produced Robust Antibodies and T cells Against SARS-CoV-2
Mar 10, 2022 09:00AM Data Published in a Lancet Journal on COH04S1, a City of Hope-Developed COVID-19 Vaccine, Shows It Produced Robust Antibodies and T Cells Against SARS-CoV-2
Nov 9, 2021 04:00PM Geovax Labs Inc. (GOVX) and City of Hope to Accelerate Development and Commercialization for City of Hope's COVID-19 Vaccine
Nov 9, 2021 04:00PM GeoVax and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope's COVID-19 Vaccine
Nov 9, 2021 04:00PM GeoVax and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope's COVID-19 Vaccine
Mar 12, 2019 09:00AM GeoVax Selected as Finalist for Vaccine Industry Excellence Awards
Mar 11, 2019 09:00AM GeoVax Provides Product Development and Corporate Update
Mar 11, 2019 05:00AM GeoVax Provides Product Development and Corporate Update
Jan 2, 2019 07:34AM Geovax Labs, Inc. (GOVX) Announces Collaboration with Enesi Pharma to Development of Multiple Vaccines Administered by ImplaVax
Jan 2, 2019 07:30AM GeoVax and Enesi Pharma to Collaborate on Development of Multiple Vaccines Administered by ImplaVax®, a Novel Needle-Free Vaccine Delivery Platform
Nov 8, 2018 12:18PM GeoVax Reports 2018 Third Quarter Financial Results and Provides Corporate Update
Aug 7, 2018 01:00PM GeoVax Reports 2018 Second Quarter Financial Results and Provides Corporate Update